Legal Representation
Attorney
Tracy-Gene G. Durkin
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 10, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 26, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Sep 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 20, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 7, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 20, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 7, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 9, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 9, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 9, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 10, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 10, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 12, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 10, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 10, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 10, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 11, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 6, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 6, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 6, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 6, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 30, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 29, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 29, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 28, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 30, 2018 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 30, 2018 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 30, 2018 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 29, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 28, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 28, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 29, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 29, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 22, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment and prevention of cancer
Class 042
Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals
Class 044
Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
Additional Information
Design Mark
The mark consists of the stylized letters "A", "D", "C", and "T".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044